Amee Majmundar, MD
Allergy & Immunology · Orland Park, ILNPI 1093794620
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by CSL Behring at 30.2% of the total. 2025 is the largest year on record at $6,651, more than ten times the $383 reported in 2019.
Across 227 payments — averaging $51.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$4K
- Sanofi$2K
- Genentech USA, Inc.$1K
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$973
- Novartis$343
- plus $2K from 23 others
What the payments were for
- Consulting fees$5,58548%
- Travel & lodging$6175%
- Food & beverage$5,37946%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 18 | $3,500 |
| Sanofi | 23 | $2,421 |
| Genentech USA, Inc. | 4 | $1,367 |
| AstraZeneca | 38 | $1,056 |
| Regeneron Healthcare Solutions, Inc. | 25 | $973 |
| Novartis | 26 | $343 |
| GSK | 20 | $317 |
| Amgen | 13 | $298 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $222 |
| Biocryst US Sales Co., LLC | 5 | $158 |
| Grifols USA, LLC | 5 | $117 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $116 |
| Cranial Technologies, Inc | 6 | $90 |
| Blueprint Medicines Corporation | 3 | $85 |
| Boehringer Ingelheim | 4 | $79 |
| Pfizer | 4 | $71 |
| Novo Nordisk | 3 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Alk-abello, Inc | 2 | $37 |
| Merck | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
| Ionis Pharmaceuticals, Inc. | 1 | $33 |
| Corcept Therapeutics | 1 | $29 |
| Exact Sciences | 1 | $25 |
| Abbott | 1 | $22 |
| Optinose US, Inc. | 1 | $20 |
| Bio Products Laboratory USA, Inc. | 1 | $15 |
| Verona Pharma, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,596 in reported general payments places this provider in the 75th percentile of 161 allergy & immunology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 19 | $51,911 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $13,837 |
| DuleraMometasone/Formoterol | 17 | $6,444 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $6,008 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 23 | $5,392 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $5,365 |
| Epinephrine | 17 | $3,173 |
| Ipratropium Bromide | 95 | $2,542 |
| Levocetirizine Dihydrochloride | 110 | $2,046 |
| Montelukast Sodium | 93 | $943 |
| Azelastine Hcl | 34 | $832 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $762 |
| Doxepin Hcl | 26 | $540 |
| Triamcinolone Acetonide | 20 | $138 |
| Prednisone | 54 | $120 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta | $317 | $13,83723 claims |
| MerckDulera | $36 | $6,44417 claims |
| AstraZenecaSymbicort | $1,056 | $5,36514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 161 allergy & immunology providers in Illinois.
Other allergy & immunology in Orland Park
- Dareen SiriNormal$1.5M
- Priya BansalSaint Charles$1.3M
- Anju PetersChicago$563K
- Giselle MosnaimChicago$331K
- Patrick WinShiloh$258K
- Amanda SalihChicago$160K
- Rebecca HoffmanWilmette$160K
- Juanita MoraChicago$147K
- Sonali MajmudarAlgonquin$136K
- Zachary RubinElmhurst$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.